J.P. Morgan analyst Anupam Rama maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) on March 6 and set a price target ...

The stock's 52-week movement at Rs 17.51 and Rs 9.91. The company's market capitalisation stands at Rs 2,093 crore, which makes it a constituent of BSE Smallcap. The sharp volume surge in Rama ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In a report released on March 6, Anupam Rama from J.P. Morgan maintained a Buy rating on BridgeBio Pharma (BBIO – Research Report), with a ...